Breaking News:

Compounded Tirzepatide is no longer available nationwide

[10/02/2024 7:04 pm EDT]

The U.S. Food and Drug Administration (FDA) has announced that tirzepatide, the active ingredient in name brand medications Mounjaro® and Zepbound®, has been removed from the drug shortage list, which means compounding pharmacies are now prohibited from producing this medication under federal guidelines.

As a result, BlueRidge Meds can no longer offer access to pharmacies to fulfill compounded tirzepatide prescriptions.

We understand that this might be concerning, especially for those of you who have relied on this affordable option as part of your weight loss journey.

We want to reassure you that we are committed to providing a seamless transition and continuing your access to effective treatments.